research chemicals retatrutide (Reta GLP-3) - 99%+ Purity Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Modern management of cardiometabolic continuum: from overweight/obesity to prediabetes/type 2 diabetes mellitus

This list compares their: Medication : Primary Use // Frequency // Starting Dose // Maximum Amount Ozempic: Type 2 Diabetes // Once Weekly // 0.25 mg // 2.0 mg Wegovy : Weight Loss // Once Weekly // 0.25 mg // 2.4 mg up to 7.2 mg* T irzepatide(Mounjaro / Zepbound): Diabetes & Weight Loss // Once Weekly // 2.5 mg // 15.0 mg Retatrutide (Phase 3 Trials): Weight Loss (Investigational) // Once Weekly // 2.0 mg // 12.0 mg Effectivness Comparing data from Retatrutide clinical trials shows it to be significantly more effective for weight loss when compared to previous GLP-1 medications

GLP-1s like Ozempic, Mounjaro may also help patients with addiction

Why GLP-1 Weight Loss Can Cause Loose Skin GLP-1 medications like Wegovy and Zepbound can help patients lose a significant amount of weight, but quick changes can be challenging for skin elasticity

What Dehydration Can Look Like on GLP-1s Mild dehydration might not be obvious at first

LDN, or low dose naltrexone can actually help SOME people lose weight